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Objective. To evaluate spectral heart rate (HR) variation using short-term ECG recordings at rest and during the tilt table test.
Methods. The values of spectral components of total power (TP), high-frequency power (HF), low-frequency power (LF) and LF:
HFratioweremeasuredatrestandduringthehead-uptiltinpatientswithtemporallobeepilepsy(TLE)andtheircontrolsubjects.
Results. Compared to the control subjects, patients with TLE had lower HF (P<0.05) and LF:HF ratio (P<0.05) at rest and
lower TP (P<0.001), HF (P<0.05), and LF (P<0.05) during the head-up tilt. Upon changing from supine to standing position
TP (P<0.0 5 )a n dL F( P<0.05) were attenuated in patients with TLE compared to the control subjects. Conclusion. These results
suggest that spectral analysis of HR variation from ECG recordings of short duration may add value to assessment of autonomic
nervous system function using autonomic cardiac tests in patients with TLE.
1.Introduction
Epilepsy is well known to be associated with various auto-
nomic phenomena [1, 2]. Both ictal and interictal changes
in cardioregulatory function of the autonomic nervous
system (ANS) have been described in previous studies [3–
19]. Although their prognostic role is not yet established
in patients with epilepsy, similar changes in heart rate
(HR) variation described in patients with epilepsy have
been detected in other chronic diseases and shown to be
associated with an unfavourable prognosis in patients with
various heart conditions and cerebrovascular diseases [20–
25]. Moreover, it has been suggested that unstable cardiac
andrespiratorycontroloftheANSmaycontributetosudden
unexpected death in epilepsy (SUDEP) [26–33].
Autonomic cardiovascular regulation can be assessed
with diﬀerent methods [28, 34]. The test pattern of
autonomic cardiac function is performed under standard-
ised environmental conditions. The adaptive responses of
the ANS to various stimuli are assessed during the test [34].
Although the analysis of HR variation from an ECG of short
duration obtained during the autonomic cardiac function
tests may not be as sensitive as spectral analyses of HR
variation from 24-hour Holter recordings in revealing subtle
abnormalities in linear as well as dynamic ﬂuctuations of
HR variation, the method provides valuable information
when conducted according to the strict protocol developed
[34, 35]. Spectral analyses of HR variation can also be
performed from the short ECG recordings obtained during
the autonomic function tests. This allows assessment of
the ability of the autonomic cardioregulatory functions
to maintain the homeostasis of the body in standardized
dynamic conditions.
In this study, spectral measures of HR variation were
analysed post hoc from ECG data obtained during the
normal breathing and tilt-table tests of the autonomic
cardiac reactivity evaluation in patients with temporal lobe
epilepsy (TLE) and control subjects. The results of the2 Neurology Research International
autonomic cardiac function tests of these patients have been
previously published [8]. Spectral analysis of HR variation
from 24-hour ECG recordings has also been conducted in
these same patients, and the results showed decreased overall
autonomic cardiac regulation associated with TLE [10]. A
recent study by DeGiorgio et al. showed that low values of
certain parameters of HR variability correlate with clinical
risk markers of SUDEP [36]. Although the risk evaluation
of SUDEP cannot be solely based on ANS function, it is
important to try to develop easily accessible methods to
detect autonomic instability in epilepsy patients. Our aim
was to evaluate the value of analysing spectral HR variation
from ECG recordings obtained during autonomic cardiac
measures and further the dynamic reactivity of the cardiac
regulationinTLEpatientsduringthesetestsasatooltoassess
cardioregulatory function in these subjects.
2.MaterialsandMethods
2.1. Patients and Control Subjects. The study was carried out
attheOutpatientDepartmentofNeurologyintheUniversity
Hospital, with the approval of the Ethics Committee of the
local Medical Faculty.
Thirty-six patients with TLE who were followed up in
the Outpatient Clinic participated in the study after giving
their informed consent. Eighteen patients suﬀered from
recurrent TLE seizures despite adequate AED treatment, and
18 patients had well-controlled TLE (seizure-free on AEDs
or <2seizures/year). Both patient groups consisted of four
male and 14 female consecutive patients. The control group
consisted of 36 healthy age- and sex-matched subjects who
were either hospital staﬀ or were recruited by the staﬀ.T h e
subjects were eligible for the study if they did not have
a disease or medication known to aﬀect the ANS in their
medical history and if the complete physical examination
ﬁndings were normal.
The results of heart rate and blood pressure (BP)
responses to normal and deep breathing, tilt-table test, and
isometric work conducted with present patients and control
subjects were analysed and published previously [8]. In
short,HRvariationwaslowerinrefractoryTLEpatientsthan
in control subjects during normal breathing (P = 0.006)
and tilting (P = 0.043), and HR was also low in well-
controlled TLE patients compared to control subjects during
tilting (P = 0.036). BP responses showed no diﬀerences
between the patients and the control subjects. We were
able to successfully perform the spectral analysis of HR
variation from the ECG data of 36 patients, who represent
a subset of the original 38 patients who participated in the
autonomic cardiac function tests. The demographics of the
study patients and the control subjects are shown in Table 1.
Nine patients were taking CBZ, 11 patients were taking
oxcarbazepine(OXC),andonepatientwastakingphenytoin,
valproate, or lamotrigine each as monotherapy, and thirteen
patients were on polytherapy as a combination of two to
four of the above-mentioned antiepileptic drugs (AEDs).
In addition, vigabatrin, clonazepam, and clobazam were all
Table 1: Demographics of the study patients and the control
subjects.
No. of
patients/control
subjects
Age, years,
mean (SD)
Duration of
epilepsy years,
mean (SD)
Patients with
refractory TLE 18 33 (7) 22 (11)
Patients with
well-controlled
TLE
18 35 (6) 15 (10)
Patients, total 36 34 (7) 19 (11)
Control subjects 36 34 (7)
taken as part of polytherapy by one patient each. All thirteen
patients who were on polytherapy had refractory TLE.
All patients were carefully interviewed and clinically
examined. The epilepsy type was classiﬁed according to
the recommendations of the International League Against
Epilepsy [37]. None of the patients showed any symptoms or
signs of illness other than epilepsy known to aﬀect the ANS.
In general, the patients had neither excessive body weight,
nor elevated blood pressure. Laboratory screening (liver and
renal function, serum electrolytes, and basic hematologic
parameters) was normal in all study patients.
Patients abusing alcohol or drugs or taking any med-
ication other than AEDs known to aﬀect the ANS were
excluded. Female patients who were pregnant or lactating
were also excluded.
2.2. Methods
2.2.1. Autonomic Cardiac Function Tests. All patients and
control subjects underwent autonomic cardiac function
testing that is based on HR and BP responses at rest and after
various stimuli. All tests were performed under standardized
conditions. The measurements were performed in a silent
room with a temperature from 20 to 23◦C between 9a.m.
and 12a.m. The study subjects were asked not to smoke
or drink coﬀee within two hours and not to use alcohol
within 48 hours prior to the study. The interval between
the various tests was standardized so that the next test did
not start until the HR and BP had returned to the baseline
level after the previous test. HR and BP responses at rest
and after stimulation were recorded under the following
conditions: normal breathing, deep breathing, the Valsalva
maneuver, tilting, and isometric work (handgrip). ECG was
ﬁrst recorded during the normal breathing. Consecutive RR
intervalsweremeasuredfromtheECGforaperiodof10min
and the standard deviation of the intervals was used as
the test variable. In the tilt table test, the HR responses to
quick passive tilting (2s, 90◦) and after tilting (7min) were
recorded. A more detailed description of the methodology of
theautonomiccardiactestpatternofthepatientsandcontrol
subjects has been previously published [8, 35].
2.2.2. HRV Analysis. Spectral analysis of the RR series of
all patients and controls was performed with direct FourierNeurology Research International 3
Table 2: Heart rate variation at rest in patients with temporal lobe epilepsy (TLE) and the control subjects. The P-value presents the
diﬀerences between all patients and the control subjects.
Measure/
variable (ms2)
Patients with
refractory TLE
Patients with
well-controlled TLE All patients Control subjects P-value
(Mann-Whitney)
TP 7417 (6276, 11043) 8093 (7016, 1044) 7991 (6292, 10521) 9518 (6742, 13923 ) 0.33
HF 2471 (1752, 3622) 2954 (2092, 4397) 2729 (1979, 4265) 3954 (2855, 5705) 0.03
LF 2284 (1864, 3505) 2855 (2117, 3449) 2691 (1876, 3416) 2604 (1583, 4091) 0.54
LF:HF ratio 0.90 (0.76, 1.25 ) 0.91 (0.70, 1.12) 0.90 (0.75, 1.12) 0.84 (0.65, 1.16) 0.003
Values are median (25., 75. percentile); TP: total power; HF: high frequency; LF: low frequency.
Table 3:Heartratevariationduringhead-uptiltinpatientswithtemporallobeepilepsy(TLE)andthecontrolsubjects.TheP-valuepresents
the diﬀerences between all patients and the control subjects.
Measure/
variable (ms2)
Patients with
refractory TLE
Patients with
well-controlled TLE All patients Control subjects P-value
(Mann-Whitney)
TP 8897 (7076, 1444) 10822 (8543, 12619) 10314 (8182, 13359) 14022 (11262, 17916) <0.001
HF 2175 (1250, 3918) 2428 (2017, 3113) 2347 (1810, 3336) 3221 (2482, 4780) 0.004
LF 4248 (2525, 6035) 4326 (3682, 5687) 4248 (3198, 5633) 5800 (4308, 7142) 0.001
LF:HF ratio 1.73 (1.26, 2.31) 1.73 (1.41, 2.47) 1.73 (1.36, 2.33) 1.64 (1.35, 2.34) 0.85
Values are median (25., 75. percentile); TP: total power; HF: high frequency; LF: low frequency.
transformation[25].Thelengthofthetimeserieswas10min
for the normal breathing test and 7min for the tilt table test.
RR intervals at rest and while standing were converted to a
smoothed instantaneous RR time series at 4Hz after manual
editing of ectopic beats, and exact Hamming windowing
(cos2) was applied before Fourier transformation. Total
power (TP; 0.0033–0.40Hz) and the components of high
frequency (HF; 0.15–0.40Hz) and low frequency (LF; 0.04–
0.15Hz) were identiﬁed for each subject visually from the
Fourier series, and the HF band was manually selected
according to the calculated actual respiration frequency
spectrum. The LF:HF ratio was also calculated. The very-
low-frequencyband(VLF;0.0033–0.04Hz)wasnotincluded
in the analysis because the adequate calculation of VLF
requires a minimum of 12–16 hours of HR data [25].
2.2.3. Statistics. The nonparametric Mann-Whitney test was
usedinanalysingunevenlydistributeddata.Thediﬀerenceof
thechangesofvariousmeasuresofHRvariationfromsupine
tostandingposition wasstudiedusingtherepeatedmeasures
analysis of variance. Because of unevenly distributed data,
Tables 2 and 3 show the data as median (percentiles).
However, as the data of analysis of repeated measures follows
normal (Gaussian) distribution, the data in Table 4 is shown
as mean (SD). The P-value of the interaction describing this
change is reported in Table 4 and Figure 1.T h eP-value of
≤0.05 was considered to indicate a statistically signiﬁcant
diﬀerence. The statistical tests were performed with SPSS
14.0 software (SPSS Inc., Chicago, IL, USA).
3. Results
3.1. Supine Position. HF was decreased (P = 0.03) and the
LF:HF ratio was increased (P = 0.003) in patients with
TLE compared to the control subjects at rest. The results of
various analyses at rest are shown in Table 2. Patients with
refractoryTLEhadlowervaluesofTP,HF,andLFandhigher
LF:HF ratio than patients with well-controlled epilepsy, but
the diﬀerences were not statistically signiﬁcant.
3.2. Standing Position. During the head-up tilting TP (P<
0.001), HF (P = 0.004) and LF (P = 0.001) were low in
patients with TLE compared to the control subjects, but the
LF:HF ratio did not diﬀer between the patients and the
control subjects. The results of various analyses of head-
up tilt are shown in Table 3. Patients with refractory TLE
presented lower values of TP, HF, and LF and higher LF:HF
ratio than patients with well-controlled TLE. However, the
diﬀerences were not statistically signiﬁcant.
3.3. Change from Supine to Standing. The changes in the
powers of diﬀerent spectra during this test are shown in
Table 4.T h ed i ﬀerences of TP in changing from supine
to standing position in both patient groups and control
subjects are also shown in Figure 1. Changing from supine to
standing position resulted in signiﬁcantly lower response in
HR variation in patients with TLE compared to the controls
in TP (P = 0.04) and LF (P = 0.006). The changes in HF and
LF:HF ratio were similar in the TLE patients and the control
subjects. Although the absolute values of changes in diﬀerent
spectra were systematically lower in patients with refractory
TLE compared to patients with well-controlled TLE both in
supine and tilting position, none of these diﬀerences were
statistically signiﬁcant (Table 4, Figure 1).
4. Discussion
This study was conducted to evaluate whether spectral
analysisofHRvariationfromshortECGrecordingsobtained
during autonomic cardiac function test pattern adds value4 Neurology Research International
Table 4: The change in heart rate variation from supine to standing position in patients with temporal lobe epilepsy (TLE) and the control
subjects. The P-value presents the diﬀerences between all patients and the control subjects.
Measure/
variable (ms2)
Patients with
refractory TLE
Patients with
well-controlled TLE All patients Control subjects P-value (interaction)
TP 173 (438) 243 (222) 208 (344) 504 (596) 0.01
HF −46 (175) −70 (122) −58 (149) −68 (282) 0.85
LF 157 (231) 169 (142) 163 (189) 351 (279) 0.001
LF:HF ratio 0.90 (0.95) 0.89 (0.83) 0.89 (0.88) 1.1 (0.70 0.23
Values are mean ± SD; TP: total power; HF: high frequency; LF: low frequency.
Control subjects
Supine: 9703ms2
Standing: 14884ms2
Patients with well-controlled TLE
Supine: 889ms2
Standing: 11322ms2
Patients with refractory TLE
Supine: 830ms2
Standing: 9954ms2
P = 0.04
Standing Supine
0.8
0.9
1
1.1
1.2
1.3
1.4
1.5
Figure 1: The change of total power from supine to standing
in patients with refractory temporal lobe epilepsy (triangles), in
patients with well-controlled temporal lobe epilepsy (circles), and
the control subjects (squares). The values are estimated marginal
means. The P-value describes the signiﬁcance of the diﬀerence of
the change from supine to standing position between the patient
groups and the control subjects.
to the assessment of the ANS in patients with TLE. The
resultssuggestthatthismethodmaybeausefultooltodetect
alterations of autonomic cardiac functions. Patients with
TLE had altered HR variation already in the resting state,
and during the dynamic state (head-up tilt) these alterations
were even more pronounced. Dynamic malfunction of the
ANS of the TLE patients upon changing from supine to
tilting position was easily detected by using spectral analysis
of HR variation. At rest, the emphasis of malfunction was
on vagal modulation on the HR whereas during tilting
both the sympathetic and vagal modulation of the ANS
in TLE patients showed inferiority to that of the control
subjects. Interestingly, change from supine to standing
position revealed mainly a breakdown of the sympathovagal
balance in these patients. Although no statistically signiﬁcant
diﬀerences were detected between the two patient groups,
there was a consistent trend towards lower values of the
test parameters in the refractory TLE group, indicating a
more disrupted cardioregulatory function compared to well-
controlled TLE patients.
Previous studies have shown altered cardioregulatory
functioninpatientswithTLEincardiovascularfunctiontests
[5, 6, 8, 16, 38] and in spectral analyses of HR variation from
24-hour ECG recordings [4, 7, 10, 11, 13, 19]. Dysregulation
of the cardiac autonomic functions has been described in
association with various other diseases as well [20–24],
and the prognostic signiﬁcance of these ﬁndings has been
established in heart and cerebrovasculardiseases [20, 21, 24].
The present study agrees well with the previous studies in
that TLE aﬀects autonomic cardiac regulation. However,
this study also shows that in addition to having an overall
suppressing eﬀect on the ANS function, especially refractory
TLE seems to be associated with decreased reactivity of the
cardiovascular ANS system.
The possible contribution of AEDs to ANS dysfunction
inpatientswithepilepsyhasnotbeenclearlyestablished.Pre-
vious work has shown that CBZ alters autonomic functions
inepilepsy patients [39,40].Inonestudy, slow withdrawalof
AEDs in seizure-free epilepsy patients resulted in an increase
of both parasympathetic and sympathetic function of HR
variation [41]. Since in the current study most patients were
taking CBZ or OXC, and refractory TLE patients were on
polytherapy, it was not possible to analyse the eﬀects of
diﬀerent AEDs on HR variability. However, it is possible
that AEDs contributed to the detected alterations in the
cardioregulation, and studies designed to analyse the eﬀects
of diﬀerent AED regimens on autonomic cardiac function
are needed.
The frequency domain measure is one of the linear
analyses of the HR variation, where the power spectrum of
RR intervals reﬂects the amplitude of the HR ﬂuctuations
at diﬀerent oscillation frequencies [25]. The HF represents
the vagal modulation of the heart, the LF band represents
the sympathetic cardiac innervation and parasympathetic
activity whereas both the VLF band and the LH:HF ratio
are assumed to represent the sympathovagal balance [25].
The frequency domain analysis of HR variation, along with
various other indices are typically analysed from 24-hour
ambulatory ECG-recordings. Although this method has the
advantage that the information concerning the VLF bandNeurology Research International 5
is gathered over a longer time period [25], the ambulatory
recording may be interfered by stationary irregularities and
artefacts in consequence of the patients carrying the device
during their daily activities [42]. On the other hand, analysis
of HR variation from ECGs obtained during the provocative
autonomic testing, as shown in this study, may provide
valuable information on the reactivity of the autonomic
cardioregulation, and this method only requires a short
period of time under standardised conditions.
It is well known that various cortical and subcortical
autonomic areas control the cardiovascular function [18, 29,
43–46]. Chronic epileptiform discharges or epileptic foci in
these areas may produce potentially life-threatening cardiac
arrhythmias both ictally and interictally as cardiovascular
regulation is, in fact, a function of neuronal activity in the
cerebral cortex, the amygdale, and the medullary reticular
formation [18, 29, 43–46]. It has been suggested in the
context of increased preictal HR that in patients with
primarilymoreinstabilityandactivationincorticalnetworks
surrounding the seizure onset zone will simultaneously
increase sympathetic tone and risk for generalization of the
seizure, since noradrenergic function may be needed for
the anticonvulsive eﬀect of the vagus nerve stimulation, at
least in animals [47]. However, on the other hand, it has
also been shown that secondarily generalized seizures lead
to higher ictal HR and sustained postictal tachycardia with
enhanced shortening of QT-interval possible showing that
cardiac alterations are in fact a link between generalized
seizures and SUDEP [48]. In this study, TLE patients showed
altered sympathovagal balance in the interictal state. During
the dynamic test situation, especially refractory TLE patients
showed decreased reactivity of the cardiac autonomic func-
tions with the breakdown of sympathovagal balance. In the
future it would be interesting to study interictal and ictal
cardiac measures to evaluate whether interictal changes in
HR correlate with ictal HR changes in the same patient.
Chronic epilepsy with recurrent generalized seizures is
known to be associated with a high risk of SUDEP [49, 50].
SUDEP is the utmost consequence of numerous diﬀerent
factors that precipitate fatal complications of an epileptic
activity in a predisposed person [27, 28, 30, 31, 49–51]. As
the knowledge and understanding of the pathophysiological
background of SUDEP increases, it is necessary to continue
to develop methods to study ANS function in patients with
epilepsy along with identifying the clinical risk markers.
These methods may eventually provide tools to identify
epilepsy patients with ANS dysfunction and risk of SUDEP
and allow preventive actions.
The limitation of our study was the small number of
patients that were evaluated. It is possible that a higher
number of patients would have established more statistically
signiﬁcant diﬀerences between the study groups. Because of
the unbalanced male-to-female ratio we cannot conclude
that these results apply to both genders.
In conclusion, spectral HR variation during autonomic
function tests is a useful tool to study autonomic cardiac
regulation in patients with epilepsy. When the autonomic
cardiac function tests are performed under standardized
laboratory conditions according to a regular protocol,
the method is reliable. The reactivity of the cardioregulatory
functions can be assessed more carefully by including
spectralanalysisofHRvariationintothestudyprotocol.TLE
patients showed a sympathovagal malfunction during the
dynamic test situation. This was even more pronounced in
patientswithrefractoryTLE.AlthoughreducedHRvariation
is not considered a direct indication of elevated risk of
SUDEP, the inferior capacity of the ANS to react during
dynamic situations may be a manifestation of autonomic
imbalance during generalized epileptic seizures.
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